Greenwich Lifesciences Inc
GLSI11.100USD
+0.010+0.09%
交易中 （美东）报价延迟15分钟
146.44M总市值
亏损市盈率 TTM
关于 Greenwich Lifesciences Inc 公司
Greenwich LifeSciences, Inc. 是一家临床阶段的生物制药公司。该公司专注于开发 GP2，这是一种用于预防乳腺癌复发的免疫疗法，适用于之前接受过手术的患者。GP2 是人类表皮生长因子受体 2 (HER2)/neu 蛋白的 9 个氨基酸跨膜肽，这是一种在多种常见癌症中表达的细胞表面受体蛋白。GP2 与粒细胞-巨噬细胞集落刺激因子结合使用，以诱导 GP2 肽特异性免疫。GP2 治疗通过皮内注射给药，在给药时将 GP2 肽和 GM-CSF 混合。其癌症免疫疗法旨在刺激个体的免疫系统选择性地攻击癌细胞，同时不影响正常细胞，或传递免疫系统成分以抑制癌症扩散。该公司已开始 III 期临床试验，Flamingo-01 是一种用于预防乳腺癌复发的免疫疗法。
公司简介
公司代码GLSI
公司名称Greenwich Lifesciences Inc
上市日期Sep 25, 2020
CEOMr. Snehal Patel
员工数量4
证券类型Ordinary Share
年结日Sep 25
公司地址3992 Bluebonnet Dr, Building 14
城市STAFFORD
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编77477
电话12034343290
网址https://greenwichlifesciences.com
公司代码GLSI
上市日期Sep 25, 2020
CEOMr. Snehal Patel
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Snehal Patel
Mr. Snehal Patel
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
5.57M
+0.33%
Mr. David B. Mcwilliams
Mr. David B. Mcwilliams
Independent Chairman of the Board
Independent Chairman of the Board
620.33K
--
Mr. Kenneth Hallock
Mr. Kenneth Hallock
Independent Director
Independent Director
397.33K
--
Mr. Eric Rothe
Mr. Eric Rothe
Independent Director
Independent Director
313.25K
--
Dr. Jaye Thompson, Ph.D.
Dr. Jaye Thompson, Ph.D.
Vice President - Clinical & Regulatory Affairs
Vice President - Clinical & Regulatory Affairs
--
--
Dr. F. Joseph Daugherty, M.D.
Dr. F. Joseph Daugherty, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Snehal Patel
Mr. Snehal Patel
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
5.57M
+0.33%
Mr. David B. Mcwilliams
Mr. David B. Mcwilliams
Independent Chairman of the Board
Independent Chairman of the Board
620.33K
--
Mr. Kenneth Hallock
Mr. Kenneth Hallock
Independent Director
Independent Director
397.33K
--
Mr. Eric Rothe
Mr. Eric Rothe
Independent Director
Independent Director
313.25K
--
Dr. Jaye Thompson, Ph.D.
Dr. Jaye Thompson, Ph.D.
Vice President - Clinical & Regulatory Affairs
Vice President - Clinical & Regulatory Affairs
--
--
Dr. F. Joseph Daugherty, M.D.
Dr. F. Joseph Daugherty, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
持股股东
占比
Patel (Snehal)
41.67%
McWilliams (David B)
4.64%
Hallock (Kenneth)
2.97%
BlackRock Institutional Trust Company, N.A.
2.41%
Rothe (Eric)
2.34%
Other
45.97%
持股股东
持股股东
占比
Patel (Snehal)
41.67%
McWilliams (David B)
4.64%
Hallock (Kenneth)
2.97%
BlackRock Institutional Trust Company, N.A.
2.41%
Rothe (Eric)
2.34%
Other
45.97%
股东类型
持股股东
占比
Individual Investor
54.28%
Investment Advisor
5.86%
Investment Advisor/Hedge Fund
2.35%
Hedge Fund
0.85%
Pension Fund
0.20%
Research Firm
0.15%
Bank and Trust
0.05%
Other
36.26%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
105
8.52M
63.74%
-338.41K
2025Q1
106
8.50M
64.50%
-388.04K
2024Q4
96
8.34M
63.41%
-410.99K
2024Q3
92
8.47M
64.65%
-203.33K
2024Q2
92
8.33M
64.66%
+241.77K
2024Q1
97
7.76M
60.42%
-184.06K
2023Q4
95
7.62M
59.30%
-311.10K
2023Q3
103
7.60M
59.17%
-679.19K
2023Q2
102
7.68M
59.81%
-652.02K
2023Q1
106
7.87M
61.24%
-314.63K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Patel (Snehal)
5.57M
41.67%
+18.10K
+0.33%
Apr 25, 2025
McWilliams (David B)
620.33K
4.64%
--
--
Apr 11, 2025
Hallock (Kenneth)
397.33K
2.97%
--
--
Apr 11, 2025
BlackRock Institutional Trust Company, N.A.
321.62K
2.41%
-5.91K
-1.81%
Mar 31, 2025
Rothe (Eric)
313.25K
2.34%
--
--
Apr 11, 2025
The Vanguard Group, Inc.
270.31K
2.02%
-4.68K
-1.70%
Mar 31, 2025
Thompson (Jaye L)
264.14K
1.98%
+1.00K
+0.38%
Nov 21, 2024
Geode Capital Management, L.L.C.
137.01K
1.02%
+2.94K
+2.19%
Mar 31, 2025
Daugherty (Frank Joseph)
90.13K
0.67%
--
--
Apr 11, 2025
DIM Funds SICAV S.A.
87.00K
0.65%
--
--
Jun 30, 2024
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
占比0.01%
Global X Russell 2000 ETF
占比0%
Proshares Ultra Russell 2000
占比0%
ProShares UltraPro Russell2000
占比0%
ProShares Hedge Replication ETF
占比0%
iShares Russell 2000 ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
